Skip to main content

Review Article

F. Randy Vogenberg, PhD, FASHP, and Murray L. Harber
Raymond K. Cross, MD, MS; Amy L. Stewart, MSN, RN, FNP-C; Colin C. Edgerton, MD, FACP, FACR, RhMSUS; Bhavesh Shah, RPh, BCOP; John A. Welz, MPH; Jonathan Kay, MD
David L. Larsen, RN, MHA; Hitesh Gandhi, MBBS; Michael Pollack, MS; Norbert Feigler, MD; Sushma Patel, PharmD; Robert A. Wise, MD
David R. Weinstein, PhD; Gary M. Owens, MD; Ankit Gandhi, PharmD
Gary Branning, MBA; Heidi C. Waters, PhD; Christy R. Houle, PhD, MPH; Stacey L. Worthy, Esq; Betsy Fink, MBA, PMP; Katie Hayes
Jack E. Fincham, PhD, RPh
Cori Gray, PharmD; Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM; Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP
Successes and Challenges of the Medicare Part D MTM Program
Jack E. Fincham, PhD, RPh
Steven R. Feldman, MD, PhD; Linda S. Cox, MD; Lindsay C. Strowd, MD; Robert A. Gerber, PharmD, MA, MBA; Steven Faulkner, PharmD, MBA; Debra Sierka, PharmD; Timothy W. Smith, BA; Joseph C. Cappelleri, PhD; Mark E. Levenberg, DO
Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges
Gary M. Owens, MD
Raghu Durvasula, MD, MHA; Janet Kelly, PharmD; Anneliese Schleyer, MD, MHA; Bradley D. Anawalt, MD; Shabir Somani, MS, MBA, RPh, FASHP; Timothy H. Dellit, MD
Pharmacy & Therapeutics Committees’ New Challenge: Stewardship for Specialty Drugs
Byron C. Scott, MD, MBA

Results 1 - 9 of 9